Literature DB >> 31108317

New players in phototherapy: photopharmacology and bio-integrated optoelectronics.

Johannes Morstein1, Dirk Trauner2.   

Abstract

Photodynamic therapy and phototherapy are used in the clinic to treat dermatological conditions, cancer, macular degeneration, and a variety of other diseases. Despite their long history and widespread application, the scope of these therapeutic approaches has been limited by a lack of specificity and challenges with light delivery. In recent years, much progress has been made in these regards. Photopharmacology has provided drug-like molecules that change their efficacy upon irradiation and allow for the optical control of a wide range of defined biological targets. Many photopharmaceuticals are now used in vivo and some show promising results in preclinical development. At the same time, new bioelectronics for subdermal light delivery have been engineered that could enable phototherapy deep in tissue, for example within the human brain. These developments could increase the impact of photodynamic therapy in human precision medicine.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 31108317     DOI: 10.1016/j.cbpa.2019.03.013

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  8 in total

1.  Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions.

Authors:  John Roque; Dmytro Havrylyuk; Patrick C Barrett; Tariq Sainuddin; Julia McCain; Katsuya Colón; William T Sparks; Evan Bradner; Susan Monro; David Heidary; Colin G Cameron; Edith C Glazer; Sherri A McFarland
Journal:  Photochem Photobiol       Date:  2019-12-06       Impact factor: 3.421

2.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

3.  Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?

Authors:  Francisco Ciruela; Kenneth A Jacobson
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

4.  A Photoswitchable Inhibitor of the Human Serotonin Transporter.

Authors:  Bichu Cheng; Johannes Morstein; Lucy Kate Ladefoged; Jannick Bang Maesen; Birgit Schiøtt; Steffen Sinning; Dirk Trauner
Journal:  ACS Chem Neurosci       Date:  2020-04-23       Impact factor: 4.418

5.  Light-Controlled Cell-Cycle Arrest and Apoptosis.

Authors:  Edgar Uhl; Friederike Wolff; Sriyash Mangal; Henry Dube; Esther Zanin
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-23       Impact factor: 15.336

6.  An Eight-State Molecular Sequential Switch Featuring a Dual Single-Bond Rotation Photoreaction.

Authors:  Aaron Gerwien; Benjamin Jehle; Marvin Irmler; Peter Mayer; Henry Dube
Journal:  J Am Chem Soc       Date:  2022-02-14       Impact factor: 15.419

7.  Optical control of the nuclear bile acid receptor FXR with a photohormone.

Authors:  Johannes Morstein; Julie B Trads; Konstantin Hinnah; Sabine Willems; David M Barber; Michael Trauner; Daniel Merk; Dirk Trauner
Journal:  Chem Sci       Date:  2019-11-19       Impact factor: 9.825

8.  Light-controllable dithienylethene-modified cyclic peptides: photoswitching the in vivo toxicity in zebrafish embryos.

Authors:  Sergii Afonin; Oleg Babii; Aline Reuter; Volker Middel; Masanari Takamiya; Uwe Strähle; Igor V Komarov; Anne S Ulrich
Journal:  Beilstein J Org Chem       Date:  2020-01-07       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.